"Heparin per se has very low immunogenicity (it’s not a protein), and hence any immunogenicity that might be caused by a heparin-based drug would likely stem from impurities in the manufacturing process"
in vivo heparin can be immunogenic (heparin-induced thrombocytopenia is an immune-medated side effect)